THE LANCET - Tocilizumab in patients with severe COVID-19: a retrospective cohort study

THE LANCET - Tocilizumab in patients with severe COVID-19: a retrospective cohort study

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30173-9/fulltext

28 de junho de 2020

Categorias

Categorias

Arquivo de Notícias

Arquivo